A team of scientists from University Hospitals – Case Medical Center will present research at a conference in California showing that a new oral antiseptic spray is capable of eliminating 99.9 percent of infectious airborne germs.
The research, to be shown in two presentations at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco, culminated in the development of Halo Oral Antiseptic, according to CIDRAP News.
“Respiratory tract disease is a major cause of morbidity and mortality throughout the world,” Dr. Frank Esper, a disease expert at UH Rainbow Babies & Children’s Hospital and a lead author of one of the studies, said, CIDRAP News reports. “Yet there has been limited progress in the prevention of respiratory virus infections. Halo is unique in that it offers protection from airborne germs such as influenza and rhinovirus.”
The team tested Halo against clinical strains of 2009 H1N1 pandemic influenza in order to demonstrate its anti-infective activity in cell cultures.
Halo consists of glycerine and xanthan gum as a microbial barrier combined with cetylpyridinium chloride as the primary anti-infective agent.
“The glycerine and xanthan gum prevent the germs from entering a person’s system and the CPC kills the germs once they’re trapped there,” Dr. Esper said, according to CIDRAP News.